藥品產業患者聽從指示度及疾病管理：計畫發展、管理及改善

本報告已在2011年12月09日停止出版。

簡介

封面圖片：

目錄

Abstract

Increase the effectiveness of your patient adherence and disease management programs:

This report provides benchmarks for patient adherence and disease management organizational structures, resource investments, tactics and improvement processes. Explore some of the industry' s most innovative programs, from leadership involvement to budgets to common program challenges.

Pharmaceutical Patient Adherence and Disease Management is designed in a reader-friendly format so you can easily access information according to interest and need. The report is broken down into four chapters:

• Structures, Headcounts and Investment - Learn how industry leaders draw on multiple functions to develop well-rounded campaigns. Explore timing of team assembly and investment levels of various programs.
• Program Management - Discover how the most successful programs rely on market research to develop customized messages and launch targeted efforts across various media channels. Study companies' strategies to achieve patient buy-in and overcome program challenges.
• Opportunity and Improvement - Investigate the business opportunity of addressing non-adherence. Uncover companies' strategies and tactics to improve their initiatives and the latest innovations on the adherence front.
• Real-World Program Details - Analyze real-world programs' resources, compliance rates, development timeframes and media mixes.

Table of Contents

Chapter 1:

• Percentage of companies' portfolios supported by patient adherence programs
• Percentage of companies' portfolios supported by disease management programs
• Functions involved in program development and maintenance
• Program team leadership
• Team sizes throughout program launch and maintenance
• Lifecycle stage in which companies assemble program teams
• Percentage of programs' development budgets that are outsourced
• Percentage of companies outsourcing specific program activities
• Investment in program development from concept to implementation
• Annual program maintenance investment

Chapter 2:

• Percentage of companies that have non-branded disease awareness campaigns
• Percentage of companies leveraging various media channels
• Examples of pharmaceutical adherence tools
• Companies' ratings of program challenges
• Percentage of companies with outcome measurements in place to measure ROI

Chapter 3:

• Percentage of average drugs' foregone sales due to adherence issues
• Brand websites most visited by physicians

Chapter 4 contains 18 program profiles, which each contain the following metrics and graphics:

• Program background information: condition status, global launch, brand/therapeutic area peak annual sales
• Percentage of patients compliant at various treatment stages
• Cost to attain a new patient vs. cost to retain an existing patient
• Percentage of current overall marketing budget spent on patient adherence/disease management
• Program funding sources
• Development budget vs. annual maintenance budget
• Percentage of development budget spent on various program activities
• Media channels leveraged in campaign
• Percentage of development budget that was outsourced
• Staff support at various program stages
• Timing of key program development activities
• ROI measurements

相關商品

Cutting Edge Information發行的製藥相關市場調查報告書

醫藥品廠牌的上市:商品化的成功方法

Launching Pharmaceutical Brands - Formulas for Commercialization Success

價格 : US $ 7695

出版日期 : 2012年04月

醫藥品產業的患者的醫囑遵從性及配合度

Pharmaceutical Patient Adherence and Compliance

價格 : US $ 7695

出版日期 : 2012年04月

美國的管理市場:透過以品質結果為支付基準成功推動商業化

US Managed Markets: Driving Commercial Success through Outcomes-Based Reimbursement

價格 : US $ 7695

出版日期 : 2012年03月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!